Firms, Experts Allowed To Stay In AndroGel MDL
Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday lost bids to disqualify two expert witnesses and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent...To view the full article, register now.
Already a subscriber? Click here to view full article